Plain-language definitions for the terms that come up across the catalog, calculator, and research guides — from reconstitution and GRAVY to GLP-1, GHRH, and Certificates of Analysis. 118 terms across 5 categories.
Sterile water with benzyl alcohol that inhibits bacterial growth in multi-use vials.
The fraction of a dose that reaches circulation intact.
Amount of peptide per unit volume of reconstituted solution.
The solvent added to a lyophilized peptide vial to reconstitute it.
Repeated freezing and thawing that degrades peptide solutions.
The time for a peptide’s circulating concentration to fall by half.
A U-100 calibrated syringe commonly used for research peptide volumes.
Injection into muscle tissue — faster absorption than subcutaneous.
Administration via the nasal mucosa — a route studied for CNS-active peptides.
Freeze-drying a peptide into a stable powder for storage.
How resistant a peptide is to degradation under storage or handling conditions.
Dissolving a freeze-dried peptide in a sterile diluent to a known concentration.
Administration into the fat layer beneath the skin.
Sterile, preservative-free water — used when single-dose vials are planned.
Attaching a fatty-acid chain to extend half-life via albumin binding.
The building-block molecules of peptides and proteins.
Replacing the C-terminal carboxyl with an amide — a common bioactivity-preserving modification.
The free-carboxyl end of a peptide chain.
A peptide whose chain forms a ring, increasing stability and receptor selectivity.
The mirror-image chirality of a standard amino acid — used to resist enzymatic degradation.
The unit of molecular mass.
A synthesis impurity missing one or more residues from the target sequence.
A covalent bond between two cysteine residues that stabilizes structure.
Grand Average of Hydropathy — a sequence’s mean hydrophobicity.
High-performance liquid chromatography — the standard purity test for peptides.
How water-attracting or water-repelling an amino acid is.
The pH at which a peptide carries no net charge.
An analytical technique that confirms molecular identity by measuring mass.
The mass of a molecule, expressed in daltons.
Capping the N-terminus with an acetyl group to improve stability.
The free-amino end of a peptide chain.
Attaching polyethylene glycol chains to extend half-life and reduce immunogenicity.
A short chain of amino acids linked by peptide bonds.
The amide bond linking one amino acid to the next.
A temporary chemical block used in SPPS to prevent unwanted side reactions.
A single amino acid unit within a peptide chain.
The solid support to which the growing peptide chain is anchored during SPPS.
The ordered list of amino acids in a peptide.
Solid-phase peptide synthesis — the primary method for manufacturing research peptides.
Trifluoroacetate counterion — a common byproduct of SPPS that appears in the final peptide.
A tetrapeptide fragment of thymosin β4 with anti-inflammatory and anti-fibrotic activity.
A molecule that binds and activates a receptor.
AMP-activated protein kinase — the cell's central energy-sensing enzyme.
The formation of new blood vessels from existing ones.
A class of innate-immunity peptides that directly kill or disable pathogens.
The cell's recycling system — disposing of damaged proteins and organelles.
Brain-derived neurotrophic factor, a target of cognition research.
The selective barrier between blood and brain tissue that restricts most peptides from entering the CNS.
Cyclic AMP — the second messenger downstream of many GPCR-linked peptide receptors.
An inner-mitochondrial-membrane lipid essential for energy production.
The most abundant structural protein — a primary target in wound healing research.
The primary stress glucocorticoid — relevant to GH-axis peptide research.
The enzyme that rapidly degrades incretins like GLP-1.
Gene expression changes that don't alter the DNA sequence — methylation, acetylation, etc.
The cell type responsible for synthesizing collagen and extracellular matrix.
The rate at which the stomach empties its contents into the small intestine.
The endogenous "hunger hormone" and natural ligand for the GHS-R1a receptor.
Growth hormone-releasing hormone — the hypothalamic GH signal.
Growth hormone-releasing peptides acting on the ghrelin receptor.
Growth hormone secretagogue receptor 1a — the target of GHRPs and ghrelin.
Glucose-dependent insulinotropic polypeptide, a second incretin.
Glucagon-like peptide-1, an incretin targeted for diabetes and weight loss.
The counter-regulatory hormone to insulin — raises blood glucose; targeted by triple agonists.
The hypothalamic-pituitary-gonadal hormone feedback system.
Insulin-like growth factor 1, the downstream mediator of GH.
Adjusting immune activity up or down — not wholesale suppression.
Gut hormones that boost insulin release after eating.
Reduced cellular response to insulin — a driver of type 2 diabetes and metabolic syndrome.
The liver's production of ketone bodies from fatty acids during carbohydrate restriction.
The master upstream regulator of the reproductive hormone axis.
The biochemical processes by which fats are synthesized, stored, and broken down.
A receptor/peptide family regulating pigmentation, energy, and sexual function.
A kinase that integrates nutrient signals and regulates cell growth and aging.
A coenzyme central to energy metabolism that declines with age.
A peptide that acts as a signaling molecule in the nervous system.
A master transcription factor controlling inflammatory gene expression.
A gaseous signaling molecule mediating vasodilation and tissue repair.
Cellular damage from excess reactive oxygen species — a driver of aging.
A pituitary hormone that some GH secretagogues elevate as a side effect.
The natural pattern of growth hormone secretion — bursts followed by troughs.
A protein that binds a signaling molecule and initiates a cellular response.
A substance that triggers secretion of a hormone.
An agent that clears senescent “zombie” cells.
The ability of synapses to strengthen or weaken in response to activity — the basis of learning.
Protective caps on chromosomes that shorten with each cell division — a marker of biological aging.
Pattern-recognition receptors of innate immunity that detect microbial motifs.
Vascular endothelial growth factor — the primary driver of new blood vessel formation.
Alpha-melanocyte-stimulating hormone — the master endogenous melanocortin peptide.
A unique registry identifier for a chemical substance.
A supplier document reporting a compound’s identity and purity.
International Nonproprietary Name — the WHO-assigned generic name for a drug substance.
The count of each atom type in a molecule.
An FDA designation that incentivises development for rare diseases (< 200,000 US patients).
A unique compound identifier in NIH’s PubChem database.
A designation indicating a compound is sold for in vitro or non-clinical research, not human use.
A line notation for encoding molecular structure as a text string.
A reference database of protein sequence and function.
Listed on the World Anti-Doping Agency's prohibited substance list for competitive sports.
Any undesirable experience occurring in a trial participant — reported and graded.
A measure of how tightly a compound binds to or activates its receptor target.
A measurable biological indicator used to track disease or treatment response.
The staged structure of human clinical trials (Phase 1–4).
How the magnitude of an effect changes with increasing dose.
Neither participants nor investigators know who received treatment — the strongest bias control.
The outcome measured in a clinical trial to assess treatment effect.
Cleared by the U.S. FDA as safe and effective for a specific use.
Hypoactive sexual desire disorder, a melanocortin-peptide endpoint.
Research performed in cell cultures or isolated tissues outside a living organism.
Research performed in living organisms — animal models or humans.
A liver disease studied as a metabolic-peptide endpoint.
Prescribing an approved drug outside its approved indication.
Research evaluated by independent scientific experts before publication.
What a drug does to the body — receptor binding, downstream effects, dose-response.
How the body absorbs, distributes, metabolizes, and excretes a drug — ADME.
An inert comparator used in controlled trials to isolate treatment effects.
Studies conducted before human trials — cell, tissue, and animal models.
The gold-standard trial design — participants randomly assigned to treatment or control.
A structured synthesis of all eligible studies on a research question.
Research use only. Definitions are educational references, not medical advice or dosing guidance. Independent validation required for any experimental use.
Looking for compounds instead of definitions?
Browse the catalog